IBDEI1ER ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22773,1,3,0)
 ;;=3^Sezary Disease,Inguinal Region/LE Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22773,1,4,0)
 ;;=4^C84.15
 ;;^UTILITY(U,$J,358.3,22773,2)
 ;;=^5001636
 ;;^UTILITY(U,$J,358.3,22774,0)
 ;;=C84.18^^76^978^32
 ;;^UTILITY(U,$J,358.3,22774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22774,1,3,0)
 ;;=3^Sezary Disease,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22774,1,4,0)
 ;;=4^C84.18
 ;;^UTILITY(U,$J,358.3,22774,2)
 ;;=^5001639
 ;;^UTILITY(U,$J,358.3,22775,0)
 ;;=C84.17^^76^978^33
 ;;^UTILITY(U,$J,358.3,22775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22775,1,3,0)
 ;;=3^Sezary Disease,Spleen
 ;;^UTILITY(U,$J,358.3,22775,1,4,0)
 ;;=4^C84.17
 ;;^UTILITY(U,$J,358.3,22775,2)
 ;;=^5001638
 ;;^UTILITY(U,$J,358.3,22776,0)
 ;;=C84.10^^76^978^34
 ;;^UTILITY(U,$J,358.3,22776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22776,1,3,0)
 ;;=3^Sezary Disease,Unspec Site
 ;;^UTILITY(U,$J,358.3,22776,1,4,0)
 ;;=4^C84.10
 ;;^UTILITY(U,$J,358.3,22776,2)
 ;;=^5001631
 ;;^UTILITY(U,$J,358.3,22777,0)
 ;;=A53.9^^76^978^50
 ;;^UTILITY(U,$J,358.3,22777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22777,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,22777,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,22777,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,22778,0)
 ;;=L90.5^^76^978^18
 ;;^UTILITY(U,$J,358.3,22778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22778,1,3,0)
 ;;=3^Scar-Atrophic/Painful
 ;;^UTILITY(U,$J,358.3,22778,1,4,0)
 ;;=4^L90.5
 ;;^UTILITY(U,$J,358.3,22778,2)
 ;;=^5009455
 ;;^UTILITY(U,$J,358.3,22779,0)
 ;;=L91.0^^76^978^19
 ;;^UTILITY(U,$J,358.3,22779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22779,1,3,0)
 ;;=3^Scar-Hypertrophic/Keloidal
 ;;^UTILITY(U,$J,358.3,22779,1,4,0)
 ;;=4^L91.0
 ;;^UTILITY(U,$J,358.3,22779,2)
 ;;=^5009459
 ;;^UTILITY(U,$J,358.3,22780,0)
 ;;=Z48.02^^76^978^49
 ;;^UTILITY(U,$J,358.3,22780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22780,1,3,0)
 ;;=3^Suture Removal
 ;;^UTILITY(U,$J,358.3,22780,1,4,0)
 ;;=4^Z48.02
 ;;^UTILITY(U,$J,358.3,22780,2)
 ;;=^5063035
 ;;^UTILITY(U,$J,358.3,22781,0)
 ;;=C44.1292^^76^978^4
 ;;^UTILITY(U,$J,358.3,22781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22781,1,3,0)
 ;;=3^SCC Skin Left Eyelid,Incl Canthus
 ;;^UTILITY(U,$J,358.3,22781,1,4,0)
 ;;=4^C44.1292
 ;;^UTILITY(U,$J,358.3,22781,2)
 ;;=^5157264
 ;;^UTILITY(U,$J,358.3,22782,0)
 ;;=C44.1222^^76^978^13
 ;;^UTILITY(U,$J,358.3,22782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22782,1,3,0)
 ;;=3^SCC Skin Right Eyelid,Incl Canthus
 ;;^UTILITY(U,$J,358.3,22782,1,4,0)
 ;;=4^C44.1222
 ;;^UTILITY(U,$J,358.3,22782,2)
 ;;=^5157262
 ;;^UTILITY(U,$J,358.3,22783,0)
 ;;=Z76.89^^76^978^24
 ;;^UTILITY(U,$J,358.3,22783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22783,1,3,0)
 ;;=3^Self Injection Training
 ;;^UTILITY(U,$J,358.3,22783,1,4,0)
 ;;=4^Z76.89
 ;;^UTILITY(U,$J,358.3,22783,2)
 ;;=^5063304
 ;;^UTILITY(U,$J,358.3,22784,0)
 ;;=Z13.89^^76^978^35
 ;;^UTILITY(U,$J,358.3,22784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22784,1,3,0)
 ;;=3^Skin Assessment
 ;;^UTILITY(U,$J,358.3,22784,1,4,0)
 ;;=4^Z13.89
 ;;^UTILITY(U,$J,358.3,22784,2)
 ;;=^5062720
 ;;^UTILITY(U,$J,358.3,22785,0)
 ;;=L91.8^^76^978^40
 ;;^UTILITY(U,$J,358.3,22785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22785,1,3,0)
 ;;=3^Skin Tag
 ;;^UTILITY(U,$J,358.3,22785,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,22785,2)
 ;;=^5009460
